Table 4. Factors associated with switching to NOAC.
| Odds Ratio | 95%CI | p-value | |
|---|---|---|---|
| Socio-demographics | |||
| Non-Europe (country) (ref: Spain) | 1,70 | 1.08;2.67 | 0.021 |
| Income >18.000e (ref: income ≤18.000) | 1,27 | 1.08;1.49 | 0.003 |
| Adequate INR control | 0.76 | 0.67;0.86 | 0.001 |
| Comorbidities | |||
| Renal disease | 0.69 | 0.57; 0.83 | 0.001 |
| Vascular disease | 1.34 | 1.15;1.55 | 0.001 |
| Healthcare utilisation | |||
| Primary Care visits | 1.01 | 1.00; 1.02 | 0.037 |
| Cardiology visits | 1.06 | 1.01; 1.11 | 0.018 |
| Time since Therapy initiation>6 years | 0.79 | 0.70; 0.89 | 0.001 |
n = 22629; LL: -4282.49; p: <0.0001; r2: 0.012; C Statistic: 0.59; p (X2 Hosmer Lemeshow): 0.573. Adequate INR control: TTR≥65% (ref: TTR<65%). Country (Spain, Europe, Non-Europe, Unknown) is a categorical variable. Income, comorbidity variables and Time since Therapy Initiation >6 years are dichotomous variables. Visits are quantitative variables (the variable is number of visits), and accordingly the Odds ratios refer to the odds of presenting a poor INR control with every additional visit.